Sun Pharma Advanced Research Company Limited Share Price and Company Fundamentals
Last traded: Today at 7:43 AM
Sun Pharma Advanced Research Company Limited engages in the research and development of pharmaceutical products in India and internationally. It develops Sezaby, a benzyl alcohol and propylene glycol free formulation of phenobarbital sodium injection for the treatment of neonatal seizures; SPARC-121, a novel topical agent for the treatment of Alopecia Areata; and SPARC-122, an anti-MUC1 ADC for treatment of multiple cancer indications. The company is also involved in the development of PDP-716 for treatment of open-angle glaucoma. Sun Pharma Advanced Research Company Limited was incorporated in 2006 and is based in Mumbai, India.
Key Metrics
PE ratio
4.00
PB ratio
4.74
Dividend yield
-
Beta
0.66
Market cap
₹63.43B
Enterprise value
₹69.42B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 279 |
| Website | https://sparc.life |
| Mailing address | 17/B, Mahal Industrial Estate Off Mahakali Caves Road Andheri (East) Mumbai 400093 India |
| Phone / Fax | 91 22 6645 5645 / 91 22 6645 5685 |
Dividends
Dividend yield
-
Dividend amount
₹-
Payout ratio
0.00%
5Y Avg. yield
-%
Sun Pharma Advanced Research Company Limited paid ₹- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.SPARC dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Aug 2026, following are the company executives and directors listed on Sun Pharma Advanced Research Company Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Anilkumar Raghavan | Chief Executive Officer | 57 | |
| Mr. Anup M. Rathi | Chief Financial Officer | ||
| Mr. Narendra Lakkad | Head of Corporate Development & Operations Management | ||
| Mr. Prasanna Deshmukh | Head of Human Resources & Administration | ||
| Mr. Jaydeep Issrani | Senior General Manager of Business Development, Corporate Communication & Investor Relations | ||
| Ms. Kajal K. Damania | Company Secretary & Compliance Officer | ||
| Dr. Nitin K. Damle Ph.D. | Head of Biologics | ||
| Dr. Yashoraj Zala | Senior VP & Head of Drug Delivery Systems | ||
| Dr. Vikram K. Ramanathan | Senior VP of Preclinical Development & Head of Translational Development | ||
| Dr. Venkata P. Palle | Executive VP of Small Molecule Therapeutics |
Profitability and management effectiveness
Profit margin
82.97%
Operating margin
-90.68%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Sun Pharma Advanced Research Company Limited is 63.43B and its enterprise value is 69.42B. The enterprise value to revenue ratio of SPARC is 3.64. The enterprise value to EBITDA ratio of SPARC is 4.27.
The SPARC's stocks Beta value is 0.66 making it 34% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Sun Pharma Advanced Research Company Limited (NSE:SPARC) Frequently Asked Questions
1. What is Sun Pharma Advanced Research Company Limited's Stock Symbol?
Sun Pharma Advanced Research Company Limited trades on NSE under the ticker symbol "SPARC".
2. What is Sun Pharma Advanced Research Company Limited's stock price today?
One share of SPARC stock can currently be purchased for approximately ₹195.47.
3. How can I contact Sun Pharma Advanced Research Company Limited?
Sun Pharma Advanced Research Company Limited's mailing address is 17/B, Mahal Industrial Estate Off Mahakali Caves Road Andheri (East) Mumbai 400093 India. The company can be reached via phone at 91 22 6645 5645.
4. What is Sun Pharma Advanced Research Company Limited's official website?
The official website of Sun Pharma Advanced Research Company Limited is https://sparc.life.